Immediate Impact
57 standout
Citing Papers
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Cancer statistics, 2024
2024 Standout
Works of Ekkehard Eigendorff being referenced
Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia
2015
Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ekkehard Eigendorff | 223 | 188 | 101 | 19 | 408 | |
| Romeo A. Mandanas | 166 | 39 | 92 | 21 | 456 | |
| S. Caldiera | 54 | 59 | 167 | 22 | 458 | |
| Bik To | 157 | 54 | 167 | 18 | 413 | |
| Federico Sackmann‐Muriel | 144 | 75 | 96 | 26 | 393 | |
| Ali H. Al‐Jam'a | 93 | 119 | 99 | 25 | 383 | |
| R. Grace | 145 | 51 | 68 | 17 | 347 | |
| Giuseppina Parodo | 60 | 73 | 101 | 21 | 342 | |
| Tiina M. Järvinen | 36 | 78 | 83 | 14 | 376 | |
| L Vellekoop | 305 | 111 | 142 | 17 | 449 | |
| Michele Cimminiello | 260 | 70 | 86 | 17 | 349 |
All Works
Loading papers...